NASDAQ

ContraFect to Present at 2017 World Antimicrobial Resistance Congress

YONKERS, N.Y., Sept. 11, 2017 (GLOBE NEWSWIRE) -- ContraFect Corporation (NASDAQ:CFRX), a biotechnology company ...

Apricus Biosciences Announces $3.7 Million Private Placement Priced At-The-Market

SAN DIEGO, Sept. 11, 2017 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...